Search

Your search keyword '"Aldape, Kenneth"' showing total 2,250 results

Search Constraints

Start Over You searched for: Author "Aldape, Kenneth" Remove constraint Author: "Aldape, Kenneth"
2,250 results on '"Aldape, Kenneth"'

Search Results

251. Supplementary Table 3 from Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma

252. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature

253. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

254. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways

256. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.

257. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.

258. Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature

259. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA):a molecularly distinct brain tumor type with recurrent NTRK gene fusions

260. Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial

262. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas

263. Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential Diagnosis

264. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology

265. Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning

266. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype

267. Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma

268. CIC protein instability contributes to tumorigenesis in glioblastoma

269. NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol.

270. Author Correction: Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes

272. Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review

273. Clinically oriented prediction of patient response to targeted and immunotherapies from the tumor transcriptome

277. Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy

278. Correction to: Epigenomic, genomic, and transcriptomic landscape of schwannomatosis

280. Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas

283. Sex Biases in Cancer and Autoimmune Disease Incidence Are Strongly Positively Correlated with Mitochondrial Gene Expression across Human Tissues

284. Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways

287. BIOM-46. EXPLORING CLINICAL AND PATHOLOGIC CHARACTERISTICS IN GLIOBLASTOMA LONG -TERM SURVIVORS (LTS) VERSUS SHORT-TERM SURVIVORS (STS)

288. TMIC-73. HIGH-DIMENSIONAL HISTOPATHOLOGIC EVALUATION OF THE HYPOXIC MICROENVIRONMENT IN GLIOBLASTOMA

291. EXTH-88. DOCETAXEL TARGETS AGGRESSIVE METHYLATION PROFILES AND SERVES AS A RADIOSENSITIZER IN HIGH-RISK MENINGIOMAS

294. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

295. Combined burden and functional impact tests for cancer driver discovery using DriverPower

296. Integrative pathway enrichment analysis of multivariate omics data

297. Pathway and network analysis of more than 2500 whole cancer genomes

298. Divergent mutational processes distinguish hypoxic and normoxic tumours

299. Genomic footprints of activated telomere maintenance mechanisms in cancer

Catalog

Books, media, physical & digital resources